215 related articles for article (PubMed ID: 1492007)
1. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
[TBL] [Abstract][Full Text] [Related]
2. [Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction].
Kostić T; Perisić Z; Milić D; Apostolović S; Martinović SS; Bozinović N; Mitov V; Vidanović M
Vojnosanit Pregl; 2009 Mar; 66(3):218-22. PubMed ID: 19341228
[TBL] [Abstract][Full Text] [Related]
3. Use of alteplase for myocardial infarction in two community hospitals.
Krichbaum DW; Grabavoy G; Finley RC; Hamid I
Am J Hosp Pharm; 1990 Jul; 47(7):1535-40. PubMed ID: 2114788
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
[TBL] [Abstract][Full Text] [Related]
5. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
Iakovlev VB; Gospodarenko AL; Makarenko AS
Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
[No Abstract] [Full Text] [Related]
7. Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
McLeod DC; Coln WG; Thayer CF; Perfetto EM; Hartzema AG
Ann Pharmacother; 1993; 27(7-8):956-62. PubMed ID: 8364282
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic treatment in acute myocardial infarction.
Verstraete M
Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
[TBL] [Abstract][Full Text] [Related]
9. Accelerated streptokinase--a new thrombolytic regimen in acute myocardial infarction.
Tatu-Chiţoiu G; Teodorescu C; Flueraşu A; Căpraru P; Guran M; Dan M; Chioncel V; Bumbu A; Cornaciu S
Rom J Intern Med; 1998; 36(3-4):183-96. PubMed ID: 10822515
[TBL] [Abstract][Full Text] [Related]
10. Safety of helicopter transport and out-of-hospital intravenous fibrinolytic therapy in patients with evolving myocardial infarction.
Topol EJ; Fung AY; Kline E; Kaplan L; Landis D; Strozeski M; Burney RE; Pitt B; O'Neill WW
Cathet Cardiovasc Diagn; 1986; 12(3):151-5. PubMed ID: 3089627
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery thrombolysis: comparison of approved agents.
Porter RS; DiPalma JR
Am Fam Physician; 1991 Aug; 44(2):591-8. PubMed ID: 1907085
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy in acute coronary thrombosis.
Ramalanjaona GR; Mathew JC
Indiana Med; 1990 Jun; 83(6):410-2. PubMed ID: 2112180
[TBL] [Abstract][Full Text] [Related]
13. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients.
Grijseels EW; Bouten MJ; Lenderink T; Deckers JW; Hoes AW; Hartman JA; van der Does E; Simoons ML
Eur Heart J; 1995 Dec; 16(12):1833-8. PubMed ID: 8682015
[TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
Pizzulli L; Lüderitz B
Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
[No Abstract] [Full Text] [Related]
15. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
[TBL] [Abstract][Full Text] [Related]
16. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
17. [Thrombolytic therapy in acute myocardial infarct].
Verstraete M
Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
19. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
20. Risks versus benefits: the alteplase experience.
Green JA
Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S15-9. PubMed ID: 2513714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
